EU-MARINE_ENVIRONMENTAL_POLICY-ART_3_8
EU-MARINE_ENVIRONMENTAL_POLICY-ART_3_8
Marine Environmental Policy Framework Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 2008/56/EC (Marine Strategy Framework Directive), 25 June 2008, amended by Directive 2017/845/EU, 18 May 2017
This list contains a non-exhaustive inventory of hazardous substances for purposes of the Marine Strategy Framework Directive, especially as it concerns Art. 3(8), and Annexes I and III. The listed substances meet the European Union's definitions as hazardous, as provided on: (1) Table 3 of Annex VI to the CLP Regulation (1272/2008/EC); (2) Annex III of Directive 2000/54/EC (Biological Agents); Candidate List of SVHCs; and REACH Annex XIV (Authorisation List).
Last updated 25 April 2024. Database contains 5402 unique substances/entries.
Filter the list
|
-
|
-
|
yes |
||||
|
show/hide
|
700-960-7
|
-
|
yes |
|||
|
-
|
-
|
yes |
C1B Carcinogenic, Category 1B. |
|||
|
An inorganic pigment that is the reaction product of high temperature calcination in which nickel (II) oxide and silicon oxide in varying amounts are homogeneously and ionically interdiffused to form a crystalline matrix of olivine. Its composition may include any one or a combination of the modifiers alkali or alkaline earth halides.
|
271-112-7
|
68515-84-4
|
yes |
|||
|
214-197-8
|
1113-02-6
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
P Parasites |
||||
|
-
|
-
|
P Parasites |
||||
|
-
|
-
|
P Parasites |
||||
|
215-235-6
|
1314-41-6
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
show/hide
(2',7'-dibromo-3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-4'-yl)hydroxymercury
EC / List no:
259-779-2
| CAS no:
55728-51-3
Hydrogen triiodomercurate(1-), compound with 3-methyl-3H-benzothiazol-2-imine (1:1)
EC / List no:
276-613-4
| CAS no:
72379-35-2
Mercury, phenyl((2-phenyldiazenecarbothioic acid-kappaS) 2-phenylhydrazidato-kappaN2)-
EC / List no:
-
| CAS no:
12406-51-8
[μ-[(oxydiethylene but-2-enedioato)(2-)]]diphenyldimercury
EC / List no:
301-791-8
| CAS no:
94070-92-5
(4-((4-(Dimethylamino)phenyl)azo)phenyl)mercuric acetate
EC / List no:
631-561-5
| CAS no:
19447-62-2
2-hydroxy-5-(1,1,3,3-tetramethylbutyl)phenylmercury acetate
EC / List no:
209-534-0
| CAS no:
584-18-9
[2,2',2''-nitrilotri(ethanol)-N,O,O',O'']phenylmercury lactate
EC / List no:
245-581-3
| CAS no:
23319-66-6
Hydrogen [metasilicato(2-)-O](2-methoxyethyl)mercurate(1-)
EC / List no:
264-920-6
| CAS no:
64491-92-5
Sodium [3-[[(3-carboxylatopropionamido)carbonyl]amino]-2-methoxypropyl]hydroxymercurate(1-)
EC / List no:
231-532-3
| CAS no:
7620-30-6
Tetrakis(acetato-O)[μ4-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',4',5',7'-tetrayl)]tetramercury
EC / List no:
259-075-5
| CAS no:
54295-90-8
Butanoic acid, 4-((((2-methoxypropyl)amino)carbonyl)amino)-4-oxo-, mercury complex
EC / List no:
-
| CAS no:
72-58-2
Cyclopentanecarboxylic acid, 3-(((3-mercapto-2-methoxypropyl)amino)carbonyl)-2,2,3-trimethyl-, mercury complex
EC / List no:
-
| CAS no:
76-31-3
Hydrogen [3-[(α-carboxylato-o-anisoyl)amino]-2-hydroxypropyl]hydroxymercurate(1-)
EC / List no:
247-796-8
| CAS no:
26552-50-1
Mercurate(1-), [dodecenylbutanedioato(2-)-O']phenyl-, hydrogen
EC / List no:
304-575-1
| CAS no:
94276-88-7
Turpentine, Venice, sulfurized, reaction products with hydrogen tetrachloroaurate(-1), sulfurized turpentine oil and mercurous nitrate, mixed with mercurous oxide
EC / List no:
293-784-0
| CAS no:
91082-69-8
Diphenyl[μ-[(tetrapropenyl)succinato(2-)-O:O']]dimercury
EC / List no:
248-355-2
| CAS no:
27236-65-3
[2,5-dichloro-3,6-dihydroxy-2,5-cyclohexadiene-1,4-dionato(2-)-O1,O6]mercury
EC / List no:
251-672-9
| CAS no:
33770-60-4
Mercury, (3-((((3-carboxy-1-oxopropyl)amino)carbonyl)amino)-2-methoxypropyl)hydroxy-
EC / List no:
-
| CAS no:
140-20-5
Benzenesulfonic acid, 4-hydroxy-3,5-diiodo-, mercury(2+) salt (1:1)
EC / List no:
-
| CAS no:
515-43-5
Mercury, (3-(2,5-dioxo-1-pyrrolidinyl)-2-methoxypropyl)hydroxy-, compd. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
EC / List no:
-
| CAS no:
747-23-9
Bis(acetato-O)[μ-[1,3-dioxane-2,5-diylbis(methylene)-C:C',O,O']]dimercury
EC / List no:
281-717-8
| CAS no:
84029-43-6
Bis(acetato-O)[μ-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl)]dimercury
EC / List no:
222-673-1
| CAS no:
3570-80-7
Hydrogen μ-hydroxy[μ-[orthoborato(3-)-O:O']]diphenyldimercurate(1-)
EC / List no:
304-637-8
| CAS no:
94277-53-9
Mercury, (acetato-kappaO)(3-(chloromethoxy-kappaO)propyl-kappaC)-
EC / List no:
-
| CAS no:
1319-86-4
[μ-[[4,4'-(oxydiethylene) bis(dodecenylsuccinato)](2-)]]diphenyldimercury
EC / List no:
299-418-6
| CAS no:
93882-20-3
|
-
|
-
|
yes |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
237-560-2
|
13840-56-7
|
yes |
yes |
|||
|
244-058-7
|
20816-12-0
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
211-139-3
|
630-60-4
|
yes |
||||
|
254-637-6
|
39807-15-3
|
yes |
||||
|
243-215-7
|
19666-30-9
|
yes |
||||
|
205-634-3
|
144-62-7
|
yes |
||||
|
202-464-1
|
95-92-1
|
yes |
||||
|
243-867-2
|
20543-06-0
|
yes |
||||
|
207-306-5
|
460-19-5
|
yes |
||||
|
245-445-3
|
23135-22-0
|
yes |
||||
|
604-430-5
|
144651-06-9
|
yes |
||||
|
801-263-1
|
1003318-67-9
|
yes |
||||
|
271-846-8
|
68609-97-2
|
yes |
||||
|
DAISO CCS-1S-E; S-GLYTO
|
417-210-7
|
70987-78-9
|
yes |
|||
|
LUCHEM HA-R 100; LUPERSOL HA-R 100
|
413-230-5
|
122035-71-6
|
yes |
|||
|
226-066-2
|
5259-88-1
|
yes |
||||
|
206-110-7
|
301-12-2
|
yes |
||||
|
203-430-9
|
106-75-2
|
yes |
||||
|
211-745-8
|
693-21-0
|
yes |
||||
|
211-745-8
|
693-21-0
|
yes |
||||
|
219-679-1
|
2497-07-6
|
yes |
||||
|
231-956-9
|
7782-44-7
|
yes |
||||
|
BDOMPP
|
413-430-2
|
116163-96-3
|
yes |
|||
|
250-339-5
|
30784-30-6
|
yes |
||||
|
201-280-9
|
80-46-6
|
yes |
||||
|
241-427-4
|
17404-66-9
|
yes |
||||
|
203-254-2
|
104-94-9
|
yes |
||||
|
203-405-2
|
106-51-4
|
yes |
||||
|
203-398-6
|
106-44-5
|
yes |
||||